Variability in heparin sensitivity of APTT reagents

Area of Science:

• Clinical Chemistry
• Hematology
• Pharmacology

Background:

• Activated partial thromboplastin time (APTT) is crucial for monitoring unfractionated heparin therapy.
• Significant variability exists in how different APTT reagents respond to heparin.
• Patient-specific factors also influence APTT response to heparin.

Purpose of the Study:

• To quantify the differences in heparin sensitivity among seven commercial APTT reagents.
• To assess inter-subject variability in APTT response to heparin.
• To evaluate the clinical implications of reagent variability in heparin monitoring.

Main Methods:

• Collected plasma samples from 20 healthy subjects.
• Tested seven commercially available APTT reagents: Actin, Actin FS, Automated APTT, Cephotest, Coagachek KAPTT, Platelin plus activator, and Activated Thrombofax.
• Determined the relationship between plasma heparin concentration and APTT for each reagent and subject.

Main Results:

• Demonstrated marked inter-subject variability in heparin sensitivity for all tested reagents.
• Showed significant differences in heparin sensitivity among the APTT reagents.
• Identified a 2.25-fold difference in average plasma heparin levels required to double baseline APTT between the most sensitive (0.19 U/mL) and least sensitive (0.43 U/mL) reagents.

Conclusions:

• Reagent variability in APTT testing is a significant factor contributing to potential heparin overdosage or underdosage.
• The findings underscore the critical need for the development and adoption of a standardized APTT reagent for consistent heparin monitoring.
• Clinical practice should consider the potential impact of reagent choice on therapeutic heparin management.